Guardant Health
GenomeWeb Top 40 Rises 10 Percent in January, Outpacing Gains in Broader Market
The Dow Jones Industrial Average rose 5 percent while the Nasdaq rose 2 percent, and the Nasdaq Biotech Index rose 5 percent.
In Brief This Week: Guardant Health, Genetic Signatures, Mainz Biomed, Devyser, Akoya, More
News items for the week of Jan. 27, 2025.
Barclays Initiates Coverage of Guardant Health, Exact Sciences, Natera With Overweight Rating
The investment firm cited large, unpenetrated markets for liquid biopsy in residual disease detection, monitoring, and screening.
Guardant Health Reveal Assay Gets Additional Medicare Coverage for CRC Surveillance Testing
The test was previously covered for use in colorectal cancer patients in the early postsurgical setting only.
Guardant Health, ConcertAI Partner on Combined Clinicogenomic Data-as-a-Service Offering
The companies aim to support novel drug development by providing biopharma researchers with longitudinal genomic test results paired with clinical EMR data.
Oct 29, 2024